Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

816 results

• A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment: primary endpoint results,…Phase 3Results postedn = 48NCT04627285
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 125NCT01662492
• A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 110NCT02566759
• A Teleheath tDCS Approach to Decrease Cannabis Use: Complete Statistical AnalysisIndependent statistical analysis of A Teleheath tDCS Approach to Decrease Cannabis Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05005013).Phase 2Results postedn = 52NCT05005013
• A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 23NCT02871739
• A Trial of Magnesium Dependent Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Magnesium Dependent Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01273883).Phase 3Results postedn = 38NCT01273883
• A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 291NCT00609466
• A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 499NCT04530110
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu’s Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 97NCT00556439
• Ablate-NCSIndependent statistical analysis of Cardioneuroablation for Neurocardiogenic Syncope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009982).Phase NAResults postedn = 3NCT02009982
• Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: Complete Statistical AnalysisIndependent statistical analysis of Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 30NCT02929667
• Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 4NCT01515891
• AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).Phase 2Results postedn = 15NCT01750684
• Acamprosate vs. Placebo in Bipolar Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate vs. Placebo in Bipolar Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466661).Phase 4Results postedn = 33NCT00466661
• Accelerating Word Learning in Children With Language Impairment: Complete Statistical AnalysisIndependent statistical analysis of Accelerating Word Learning in Children With Language Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01829360).Phase NAResults postedn = 35NCT01829360
• Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661840).Phase NAResults postedn = 50NCT03661840
• ACCESSIndependent statistical analysis of ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 489NCT02929108
• ACCESSIndependent statistical analysis of Adductor Canal Catheter Effectiveness and Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639128).Phase NAResults postedn = 126NCT04639128
• Acetaminophen (APAP) +/- Oxycodone: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen (APAP) +/- Oxycodone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04122443).Phase 4Results postedn = 393NCT04122443
• Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585559).Phase 3Results postedn = 44NCT00585559
• ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).Phase 2Results postedn = 14NCT00990509
• ACHIEVE IComplete statistical analysis of ACHIEVE I, a randomized, double-blind phase 3 trial of oral ubrogepant for the acute treatment of migraine with or without aura, including endpoint definitions, logistic regression, odds ratios,…Phase 3Results postedn = 1,672NCT02828020
• ACHIEVE-HIFUIndependent statistical analysis of ACHIEVE Hearing Intervention Follow-Up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070429).Phase NAResults postedn = 339NCT05070429
• ACHIEVE2Independent statistical analysis of Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 30NCT00696293
• AcTIndependent statistical analysis of the randomized phase 3 AcT trial comparing alteplase and tenecteplase in patients with acute ischemic stroke, including trial design, the modified Rankin Scale primary endpoint, planned analysis, statistical…Phase 3n = 1,600NCT03889249
• ACT IIndependent statistical analysis of ACT I (NCT00106938), a randomized trial comparing carotid artery stenting with filter versus carotid artery endarterectomy in asymptomatic subjects with significant extracranial carotid stenotic disease.Phase NAResults postedn = 1,663NCT00106938
• ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…Phase NAResults postedn = 1,663NCT00106938
• ACTHARIndependent statistical analysis of Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 4Results postedn = 5NCT03021317
• Actigraphic Analysis of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Actigraphic Analysis of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723580).Phase NAResults postedn = 1NCT00723580
• ACTIONIndependent statistical analysis of Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24…Phase 4Results postedn = 716NCT00948766
• Acupuncture for Post-Operative Pain Control for Patients Undergoing Gynecological Surgery: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture for Post-Operative Pain Control for Patients Undergoing Gynecological Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02855567).Phase NAResults postedn = 110NCT02855567
• Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01197950).Phase NAResults postedn = 303NCT01197950
• ACURASYSAn independent statistical analysis of ACURASYS (NCT00299650), a randomized, quadruple-masked phase 4 trial evaluating systematic early use of neuromuscular blocking agents in patients with ARDS.Phase 4n = 340NCT00299650
• Acute and Residual Effects of Caffeinated Beer: Complete Statistical AnalysisIndependent statistical analysis of Acute and Residual Effects of Caffeinated Beer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515294).Phase 1/2Results postedn = 154NCT00515294
• Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine: Complete Statistical AnalysisIndependent statistical analysis of Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 62NCT03951649
• Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: Complete Statistical AnalysisIndependent statistical analysis of Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611529).Phase 4Results postedn = 198NCT04611529
• Acute Neurobehavioral Program for Improving Functional Status After TBI: Complete Statistical AnalysisIndependent statistical analysis of Acute Neurobehavioral Program for Improving Functional Status After TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01166386).Phase NAResults postedn = 165NCT01166386
• Acute Pain Study Following Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of Acute Pain Study Following Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01333722).Phase 2Results postedn = 100NCT01333722
• ADAPTIndependent statistical analysis of ADAPT: Addressing Depression and Pain Together: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124188).Phase 4Results postedn = 263NCT01124188
• Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia: Complete Statistical AnalysisIndependent statistical analysis of Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04984239).Phase NAResults postedn = 20NCT04984239
• Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living: Complete Statistical AnalysisIndependent statistical analysis of Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 18NCT05956665
• Adaptive Hip Exoskeleton for Stroke Gait Enhancement: Complete Statistical AnalysisIndependent statistical analysis of Adaptive Hip Exoskeleton for Stroke Gait Enhancement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05536739).Phase NAResults postedn = 12NCT05536739
• ADAPTSC+Independent statistical analysis of Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 184NCT04818671
• Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia: Complete Statistical AnalysisIndependent statistical analysis of Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 40NCT00928564
• ADEPTIndependent statistical analysis of Anhedonia, Development, and Emotions: Phenotyping and Therapeutics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05487885).Phase 4Results postedn = 123NCT05487885
• Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine: Complete Statistical AnalysisIndependent statistical analysis of Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 76NCT03799211
• ADIOSIndependent statistical analysis of Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743520).Phase NAResults postedn = 86NCT02743520
• Adjunct Low Frequency Repetitive Transcranial Magnetic Stimulation With Physiotherapy Enhance Upper Extremity Function Restoration: Complete Statistical AnalysisIndependent statistical analysis of Adjunct Low Frequency Repetitive Transcranial Magnetic Stimulation With Physiotherapy Enhance Upper Extremity Function Restoration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 24NCT02490371
• Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit: Complete Statistical AnalysisIndependent statistical analysis of Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 9NCT02025855
• Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 129NCT05323734

← All therapeutic areas